Search results for "Osteogenesis imperfecta"

showing 10 items of 22 documents

Osteogenesis imperfecta: a clinical study of the first ten years of life.

1992

One hundred twenty-seven children with osteogenesis imperfecta (O.I.) were studied during the first 10 years of life. According to Sillence, 40 patients were assigned to type I, 39 to type III, and 48 to type IV O.I. Centiles for height, weight, and the annual number of fractures could be established for the different types of O.I. The development of the skeletal changes could be documented for the different forms of the disease. At birth, the skeletal changes were significantly more severe in type III than in type IV patients. During the first 10 years of life the number of fractures, extent of skeletal deformities, and growth retardation did not differ between types III and IV. Only fract…

Malemedicine.medical_specialtyDentinogenesis imperfectaEndocrinology Diabetes and MetabolismPoison controlShort statureBone and BonesClinical studyFractures BoneEndocrinologymedicineHumansOrthopedics and Sports MedicineLongitudinal StudiesInsulin-Like Growth Factor IChildHemihypertrophyBone Developmentbusiness.industryBody WeightInfant NewbornInfantOsteogenesis Imperfectamedicine.diseaseBody HeightSurgeryRadiographyScoliosisOsteogenesis imperfectaMotor SkillsChild PreschoolOrthopedic surgeryKidney stonesFemalemedicine.symptombusinessCalcified tissue international
researchProduct

Collagen overglycosylation: a biochemical feature that may contribute to bone quality.

2005

Skeletal ability to resist mechanical stress is determined by bone amount and quality, which relies on macro- and micro-architecture, turnover, bone matrix, and mineralisation; the role of collagen has not been clearly elucidated. Numerous post-translational steps are involved in collagen type I biosynthesis, including residue hydroxylation and glycosylation catalysed by enzymes that work until the protein folds forming the triple helix; therefore, folding rate regulates these processes. Overglycosylated hydroxylysines are poor substrates for epsilon-amino group deamination which initiates cross-link formation. Three clinical conditions associated with fractures may relate collagen overglyc…

chemistry.chemical_classificationGlycosylationGlycosylationOsteoporosisBiophysicsDeaminationCell BiologyOsteogenesis Imperfectamedicine.diseaseBiochemistryBone and BonesHydroxylationPostmenopausechemistry.chemical_compoundEnzymeBiosynthesischemistryBiochemistryDiabetes Mellitus Type 2Osteogenesis imperfectamedicineHumansCollagenMolecular BiologyTriple helixBiochemical and biophysical research communications
researchProduct

Outcome of COVID19 in Patients With Osteogenesis Imperfecta: A Retrospective Multicenter Study in Saudi Arabia

2022

BackgroundAlthough genetic diseases are rare, children with such conditions who get infected with COVID-19 tend to have a severe illness requiring hospitalization. Osteogenesis imperfecta (OI) is a rare genetic disorder of collagen resulting in fractures and skeletal deformities. Kyphoscoliosis, restrictive lung disease, and pneumonia worsen the prognosis of patients with OI. The use of bisphosphonate improves bone mineral density (BMD) and reduces fractures in OI. There is no literature describing the impact of COVID-19 in patients with OI.MethodologyA retrospective multi-center study was performed in three hospitals in Jeddah and Riyadh, Saudi Arabia, from March 1st, 2020, until August 31…

AdultMaleCOVID - 19bisphosphonateAdolescentEndocrinology Diabetes and MetabolismSaudi Arabiaosteogenesis imperfectaDiseases of the endocrine glands. Clinical endocrinologyFractures BoneYoung AdultEndocrinologyBone DensityHypothesis and TheoryHumansChildRetrospective StudiesDiphosphonatesSARS-CoV-2COVID-19PrognosisRC648-665HospitalizationfractureoutcomeFemaleFollow-Up StudiesFrontiers in Endocrinology
researchProduct

Pathological mandibular fracture after simple molar extraction in a patient with osteogenesis imperfecta treated with alendronate

2009

Osteogenesis imperfecta (OI), is a heterogeneous group of inherited disorders of connective tissue characterized by bone fragility. Patients with this disease frequently suffer fractures, over 80% of the extremities due to the more intensive mechanical load. Fractures of the facial bones occur very infrequently. Several studies have proved that bisphosphonate therapy may be effective in reducing fracture risk in OI patients. We report here an unusual case of pathological mandibular fracture following simple molar extraction in an adult patient with OI type I and oral alendronic acid treatment. Extraction was atraumatical and without bone removal . Fracture was treated by internal fixation b…

AdultMaleMolarmedicine.medical_specialtymedicine.medical_treatmentMandibular fractureConnective tissueDentistryBone healingMandibular FracturesmedicineHumansInternal fixationGeneral DentistryAlendronateDiphosphonatesbusiness.industryAlendronic acidOsteogenesis Imperfectamedicine.disease:CIENCIAS MÉDICAS [UNESCO]MolarSurgeryFractures Spontaneousmedicine.anatomical_structureOtorhinolaryngologyOsteogenesis imperfectaTooth ExtractionUNESCO::CIENCIAS MÉDICASSurgerybusinessComplicationmedicine.drug
researchProduct

Genetic disorders of connective tissues

1991

Due to the growing knowledge of structure and function of extracellular matrix proteins, congenital abnormalities of connective tissues are identified or suspected in an increasing number of clinical disorders. In osteogenesis imperfecta and two subtypes of Ehlers-Danlos syndrome, the affected matrix proteins were identified and mutations in the corresponding genes (procollagen type I and type III, respectively) could be demonstrated. Some forms of chondrodysplasia were shown to be associated with mutations in the gene encoding for the cartilage-specific collagen (type II). In part, the clinical phenotype is determined by the tissue-specific distribution of these collagens. However, the cor…

Pathologymedicine.medical_specialtyMutationbusiness.industryOsteoarthritisOsteogenesis ImperfectaMatrix (biology)medicine.disease_causemedicine.diseaseProcollagen Type IPhenotypeExtracellular matrixPhenotypeRheumatologyOsteogenesis imperfectaMutationmedicineHumansCollagenConnective Tissue DiseasesbusinessGeneCurrent Opinion in Rheumatology
researchProduct

Report of a newly indentified patient with mutations in BMP1 and underlying pathogenetic aspects

2014

et al.

MaleBiologyBone and BonesCollagen Type IBone morphogenetic protein 1Bone Morphogenetic Protein 1Extracellular matrixWestern blotBone DensityGeneticsmedicineHumansProtein precursorGenetics (clinical)medicine.diagnostic_testInfant NewbornInfantFibroblastsOsteogenesis Imperfectamedicine.diseaseMolecular biologyExtracellular MatrixRadiographyProcollagen peptidaseCollagen type I alpha 1PhenotypeOsteogenesis imperfectaMutationType I collagen
researchProduct

Association between ribs shape and pulmonary function in patients with Osteogenesis Imperfecta

2019

Graphical abstract

0301 basic medicinemusculoskeletal diseasesVital capacityPulmonary functionMedicinaKyphosisScoliosisPulmonary function testing03 medical and health sciencesFEV1/FVC ratio0302 clinical medicinemedicineRespiratory functionLung volumeslcsh:Science (General)ComputingMethodologies_COMPUTERGRAPHICSRib cagelcsh:R5-920Geometric morphometricsMultidisciplinarybusiness.industryAnatomymedicine.diseasemusculoskeletal system030104 developmental biologyScoliosis030220 oncology & carcinogenesisRib cageOriginal ArticleOsteogenesis imperfectaThoracic spinebusinesslcsh:Medicine (General)lcsh:Q1-390Journal of Advanced Research 21: 177-185 (2020)
researchProduct

Hyperplastic callus formation in osteogenesis imperfecta: CT and MRI findings.

1998

Hyperplastic callus formation is a noteworthy condition in patients with osteogenesis imperfecta because it often mimicks osteosarcoma on radiography. The findings of CT and MRI in hyperplastic callus formation have not been reported. In the presented case, MRI demonstrated contrast enhancement and edema of the surrounding soft tisssue, consistent with benign as well as malignant disease. Computed tomography showed a calcified rim of the lesion which may be a useful feature to rule out osteosarcoma in this condition.

musculoskeletal diseasesAdultmedicine.medical_specialtyRadiographyBone NeoplasmsLesionDiagnosis DifferentialEdemamedicineHyperplastic callus formationHumansRadiology Nuclear Medicine and imagingBony CallusNeuroradiologyOsteosarcomaHyperplasiamedicine.diagnostic_testTibiabusiness.industryMagnetic resonance imagingGeneral MedicineOsteogenesis Imperfectamedicine.diseaseMagnetic Resonance ImagingOsteogenesis imperfectaFibulaOsteosarcomaFemaleRadiologymedicine.symptombusinessTomography X-Ray ComputedEuropean radiology
researchProduct

Wnt1 is an Lrp5-independent bone-anabolic Wnt ligand.

2018

Wnt signaling is important for proper embryonic development, shaping cell fate and migration, stem cell renewal, and organ and tissue formation. Here, Luther et al. investigated the role of Wnt1 in osteoporosis. Patients with early-onset osteoporosis and with WNT1 mutations had low bone turnover and high fracture rates, and loss of Wnt1 activity caused fracture and osteoporosis in mice. Inducing Wnt1 in bone-forming cells increased bone mass in aged mice, and this process did not require Lrp5, a co-receptor involved in Wnt signaling. This study identifies Wnt1 as an anabolic (bone building) factor and suggests that it might be a therapeutic target for osteoporosis.WNT1 mutations in humans a…

0301 basic medicinemedicine.medical_specialtyAginganimal structuresAnabolismCellular differentiationOsteoporosis030209 endocrinology & metabolismMice TransgenicWnt1 ProteinLigandsBone and BonesBone remodeling03 medical and health sciencesFractures Bone0302 clinical medicineAnabolic AgentsOsteogenesisInternal medicineCortical BoneMedicineAnimalsHumansTransgenesOsteoblastsbusiness.industryIncidenceWnt signaling pathwayLRP5OsteoblastCell DifferentiationGeneral MedicineOrgan Sizemedicine.disease030104 developmental biologyEndocrinologymedicine.anatomical_structureLow Density Lipoprotein Receptor-Related Protein-5Osteogenesis imperfectaembryonic structuresMutationBone RemodelingbusinessScience translational medicine
researchProduct

Sonographic diagnosis of lethal osteogenesis imperfecta in the second trimester: case report and review.

1986

AdultPregnancymedicine.medical_specialtyObstetricsbusiness.industryAbortion InducedOsteogenesis Imperfectamedicine.diseaseFetal DiseasesOsteogenesis imperfectaIn uteroSecond trimesterPregnancyPregnancy Trimester SecondPrenatal DiagnosismedicineGestationHumansRadiology Nuclear Medicine and imagingFemalebusinessUltrasonographyJournal of clinical ultrasound : JCU
researchProduct